IDrugs : the investigational drugs journal

Hallek M, Girod A, Braun-Falco M, Wendtner CM, Bogedain C, Hörer M.
PMID: 18465596
IDrugs. 1998 Sep;1(5):561-73.

Recombinant adeno-associated virus (rAAV) is a promising vector for somatic gene therapy due to the ability to transduce terminally-differentiated and non-dividing cells, the lack of any apparent pathogenicity, a low immunogenicity, a relatively high stability of transgene expression, and...